Grail, Inc. (NASDAQ: GRAL) had its price target raised by analysts at Morgan Stanley from $16.00 to $20.00. They now have an "equal weight" rating on the stock.
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-Cancer Early Detection Testing [Yahoo! Finance]
GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-Cancer Early Detection Testing
GRAIL to Present at TD Cowen 45th Annual Health Care Conference